Tag: NeuroOne

NeuroOne initiates limited commercial launch of OneRF ablation system

NeuroOne Medical Technologies has announced that it has initiated a limited commercial launch of its OneRF ablation system, which has US Food and Drug Administration...

NeuroOne receives US FDA 510(k) clearance to market OneRF ablation system

NeuroOne Medical Technologies Corporation has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its OneRF ablation system for...

NeuroOne announces first clinical case using Evo sEEG electrode in robotic...

NeuroOne Medical Technologies has announced the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode in robotic neurosurgery. Performed by William Bingaman at Cleveland Clinic in Cleveland,...

NeuroOne announces US commercial launch of Evo sEEG electrodes

NeuroOne Medical Technologies has announced the commercial launch of the Evo stereoelectroencephalography (sEEG) electrode product line in the USA. Zimmer Biomet holds exclusive worldwide distribution rights...

NeuroOne completes initial animal implant of thin-film paddle lead for spinal...

NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS)....

NeuroOne successfully completes feasibility study with OneRF ablation system

NeuroOne Medical Technologies has announced that it has successfully completed a feasibility study with its OneRF ablation system—a developing technology that utilises existing implanted...

NeuroOne receives US FDA 510(k) clearance to market Evo sEEG system...

NeuroOne Medical Technologies has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its Evo stereoelectroencephalography (sEEG) electrode technology...

NeuroOne submits special 510(k) to US FDA for Evo sEEG electrode

NeuroOne Medical Technologies has announced the submission of a special 510(k) to the US Food and Drug Administration (FDA) for its stereoelectroencephalography (sEEG) electrode...

NeuroOne announces first clinical case using Evo sEEG electrode technology

NeuroOne Medical Technologies today announced that the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode was recently performed by Robert Gross at Emory University in...

NeuroOne releases successful completion of long-term stimulation tests with novel, thin-film...

NeuroOne Medical Technologies has announced that it successfully completed initial, bench-top, long-term stimulation testing on a novel design of its thin-film electrode technology. The...

NeuroOne releases successful long-term recording data with novel electrode technology

NeuroOne Medical Technologies has announced that it successfully completed initial preclinical, long-term testing of recording capabilities on its thin-film platform electrode technology. In test...

NeuroOne successfully completes feasibility study of Evo ablation electrode

NeuroOne Medical Technologies has announced the successful completion of an animal feasibility study of its combination recording and ablation technology at T3 Labs and...
neuroone evo technology

NeuroOne Medical Technologies gains FDA 510(k) clearance for Evo SEEG electrode

NeuroOne Medical Technologies—a company focused on improving surgical care options and outcomes for patients with neurological disorders—has announced that it has received US Food...